Eton Pharmaceuticals Provides Update on the FDA Review of EM-100
September 16, 2020 09:00 ET
|
Eton Pharmaceuticals
DEER PARK, Ill., Sept. 16, 2020 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products,...
Eton Pharmaceuticals Announces Appointment of Ingrid Hoos as Senior Vice President of Scientific Affairs
August 31, 2020 08:00 ET
|
Eton Pharmaceuticals
DEER PARK, Ill., Aug. 31, 2020 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products,...
Eton Pharmaceuticals Announces Second Quarter 2020 Financial Results
August 12, 2020 08:30 ET
|
Eton Pharmaceuticals
DEER PARK, Ill., Aug. 12, 2020 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products,...
Eton Pharmaceuticals Provides Update on the FDA Review of EM-100
August 11, 2020 09:00 ET
|
Eton Pharmaceuticals
DEER PARK, Ill., Aug. 11, 2020 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products,...
Eton Pharmaceuticals to Report Second Quarter Financial Results on Wednesday, August 12, 2020
August 04, 2020 16:10 ET
|
Eton Pharmaceuticals
DEER PARK, Ill., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products,...
Eton Pharmaceuticals Submits New Drug Application to the FDA for Zonisamide Oral Suspension (ET-104)
July 30, 2020 08:00 ET
|
Eton Pharmaceuticals
- Application Submitted for the Treatment of Partial Seizures in Epilepsy Patients - Eton’s Patent-Pending Product Addresses Significant Unmet Need for a Liquid Formulation of Zonisamide -...
Eton Pharmaceuticals Submits New Drug Application to the FDA for Orphan Drug Dehydrated Alcohol Injection (DS-100)
July 27, 2020 07:30 ET
|
Eton Pharmaceuticals
-Granted Orphan Drug Designation by the FDA for the Treatment of Methanol Poisoning -Since the Start of COVID-19, the FDA has Recalled More Than 75 Contaminated Hand Sanitizers Due to Risk of...
Eton Pharmaceuticals Announces First Quarter 2020 Financial Results
May 14, 2020 16:02 ET
|
Eton Pharmaceuticals
DEER PARK, Ill., May 14, 2020 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products,...
Eton Pharmaceuticals Confirms First-to-File Patent Challenge on Elcys (Cysteine Hydrochloride Injection)
May 07, 2020 08:00 ET
|
Eton Pharmaceuticals
-Eton confirms first-to-file ANDA referencing Exela Pharma Sciences’ Elcys product -Eton plans to file Post Grant Reviews in the U.S. Patent & Trademark Office challenging the validity of Exela’s...
Eton Pharmaceuticals to Report First Quarter Financial Results on Thursday, May 14, 2020
May 06, 2020 16:30 ET
|
Eton Pharmaceuticals
DEER PARK, Ill., May 06, 2020 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products,...